wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34392470-2E439E23-E4BF-460C-8DA7-B8BEB1BFB0DD
Q34392470-2E439E23-E4BF-460C-8DA7-B8BEB1BFB0DD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34392470-2E439E23-E4BF-460C-8DA7-B8BEB1BFB0DD
Selective anti-cancer agents as anti-aging drugs
P2860
Q34392470-2E439E23-E4BF-460C-8DA7-B8BEB1BFB0DD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34392470-2E439E23-E4BF-460C-8DA7-B8BEB1BFB0DD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3e7c978537db0dcb5047a50091657508dfa3eaba
P2860
Combinations of BRAF, MEK, and PI3K/mTOR inhibitors overcome acquired resistance to the BRAF inhibitor GSK2118436 dabrafenib, mediated by NRAS or MEK mutations.